期刊文献+

miR-138-5p对高糖诱导的人肾小管上皮细胞间充质转化的影响 被引量:6

Effect of miR-138-5p on the high glucose induced epithelial to mesenchymal transitionin human renal proximal tubular epithelial cells
原文传递
导出
摘要 目的研究miR-138-5p对高糖诱导的人肾小管上皮细胞间充质转化(EMT)的影响。方法将HK-2细胞分为正常组(NG,5mmol/L D-葡萄糖)、高糖组(HG,30mmol/L D-葡萄糖)、HG+miR-138-5p抑制剂转染组及HG+抑制剂对照转染组。RT-PCR检测高糖处理对miR-138-5p表达的影响;Western blot检测平滑肌肌动蛋白(α-SMA)、上皮钙黏素(E-cadherin)、同源盒蛋白A13(HOXA13)、骨形成蛋白7(BMP-7)、转化生长因子β1(TGF-β1)和Smad7等的表达;荧光素酶活性实验检测miR-138-5p与HOXA13的靶向关系。结果高糖刺激后,miR-138-5p表达升高约1.5倍(P<0.05),α-SMA表达升高1.8倍,而E-cadherin表达下降;高糖促进TGF-β1的表达,抑制HOXA13、BMP-7和Smad7的表达(P<0.05)。miR-138-5p抑制剂转染组α-SMA和E-cadherin的表达均接近NG组,且miR-138-5p抑制剂转染组TGF-β1表达下降约1.1倍,同时HOXA13、BMP-7和Smad7表达升高(P<0.05)。结论抑制MiR-138-5p表达可通过靶向调节HOXA13的表达,提高BMP-7和Smad7水平,抑制TGF-β1信号通路,进而抑制高糖诱导的HK-2细胞EMT的发生。 Objective To analyze the effect of miR-138-5 p on the high glucose induced epithelial to mesenchymal transition(EMT)in human renal proximal tubular epithelial cells.Methods The cultured HK-2 cells were divided into four groups:normal glucose group(5 mmol/L D-glucose,NG),high glucose group(30 mmol/L D-glucose,HG),HG+miR-138-5p inhibitor transfection group and HG+miR-inhibitor negative control group.The expression of miR-138-5 p was measured by Real-time PCR.The expression ofα-SMA,E-cadherin,HOXA13,BMP-7,TGF-β1,and Smad7 were measured by western blot.The target relationship between miR-138-5p and HOXA13 was measured by luciferase activity assay.Results After high glucoses timulation,the expression of miR-138-5p increased by approximately 1.5 folds andα-SMA increased by 1.8 folds,while the expression of E-cadherin reduced.High glucose stimulation also dramatically up-regulated the expression of TGF-β1,down-regulated the expression of HOXA13,BMP-7 and Smad7(P〈0.05).However,after miR-138-5 p inhibitor transfection,bothα-SMA and E-cadherin returned to similarlevel as compared with NG group.Furthermore,miR-138-5 p inhibitor dramatically decreased the expression of TGF-β1 by 1.1 folds,and increasedthe expression of HOXA13,BMP-7 and Smad7(P〈0.05).miR-138-5 p could target to HOXA13 to modulate its expression.ConclusionInhibition of miR-138-5p increased the expression of BMP-7 and Smad7,suppressed the TGF-β1 pathway by regulating the expression of HOXA13,and therefore inhibited high glucose induced EMT in HK-2 cells.
作者 王晓妮 朱兵 陈卓玥 张海雄 龙开平 WANG Xiaoni;ZHU Bing;CHEN Zhuoyue;et al(Medical School, Xijing College ,Xi' an 710123 ,China)
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2018年第1期64-68,共5页 Chinese Journal of Diabetes
基金 陕西省教育厅专项科研项目(16JK2245) 西京学院2017年科研基金(XJ170107)
关键词 miR-138-5p 高糖 人肾小管上皮细胞间充质转化 miR-138-Sp High glucose Epithelial to mesenchymal transition
  • 相关文献

参考文献6

二级参考文献87

  • 1肖瑛,石明隽,桂华珍,郭兵,张国忠.丹芪合剂对糖尿病大鼠肾小管上皮细胞骨形态发生蛋白-7和蛋白激酶Cα表达的影响[J].中草药,2009,40(S1):175-179. 被引量:2
  • 2邢静萍,陈楠.Smad与肾纤维化[J].中国中西医结合肾病杂志,2005,6(5):302-304. 被引量:15
  • 3Karihaloo A. Anti-fibrosis therapy and diabetic nephropa thy[J]. Curr Diab Rep,2012,12(4) :414-422. 被引量:1
  • 4Donnelly D. The structure and function of the glucagon- like peptide-1 receptor and its ligands[J]. Br J Pharmacol, 2012,166(1) :27-41. 被引量:1
  • 5Hendarto H, Inoguchi T, Maeda Y, et al. GLP-1 analog li- raglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD (P) H oxidases [ J ]. Metabolism, 2012,61 (10) : 1422-1434. 被引量:1
  • 6Wheeler MB, Lu M,Dillon JS, et al. Functional expression of the rat glucagonqike peptide-I receptor, evidence for coupling to both adenylyl cyclase and phospholipase-C [J]. Endocrinology, 1993,133(1) :57-62. 被引量:1
  • 7Ojima A, Ishibashi Y, Matsui T, et al. Glucagon-like pep tide-1 receptor agonist inhibits asymmetric dimethylargin- ine generation in the kidney of streptozotocin-induced dia- betic rats by blocking advanced glycation end product-in- duced protein arginine methyltranferase-1 expression[J]. Am J Pathol,2013,182(1) :132-141. 被引量:1
  • 8Panchapakesan U, Mather A, Pollock C. Role of GLP-1 and DPP-4 in diabetic nephropathy and cardiovascular disease[J]. Clin Sci,2013,124(1) : 17-26. 被引量:1
  • 9Fukami K, Yamagishi S, Ueda S, et al. Role of AGEs in diabetic nephropathy[J]. Current Pharmaceutical Design,2008,14(10):946-952. 被引量:1
  • 10Ishibashi Y, Matsui T, Takeuchi M, et al. Glucagon-like peptide-1 (GLP-1) inhibits advanced glycation end prod- uct(AGE)-induced up-regulation of VCAM-1 mRNA lev- els in endothelial cells by suppressing AGE receptor (RAGE) expression[J]. Biochem Biophys Res Commun, 2010,391 (3) : 1405-1408. 被引量:1

共引文献52

同被引文献49

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部